Public Employees Retirement System of Ohio increased its position in MEDNAX Inc (NYSE:MD) by 11.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 182,688 shares of the company’s stock after purchasing an additional 18,459 shares during the period. Public Employees Retirement System of Ohio owned approximately 0.20% of MEDNAX worth $7,878,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Fuller & Thaler Asset Management Inc. bought a new position in MEDNAX during the 3rd quarter valued at about $103,000. Pacer Advisors Inc. lifted its stake in MEDNAX by 8.1% during the 2nd quarter. Pacer Advisors Inc. now owns 1,940 shares of the company’s stock valued at $117,000 after acquiring an additional 145 shares during the period. Commonwealth Bank of Australia lifted its stake in MEDNAX by 15.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,205 shares of the company’s stock valued at $132,000 after acquiring an additional 293 shares during the period. Denali Advisors LLC bought a new position in MEDNAX during the 3rd quarter valued at about $185,000. Finally, Meiji Yasuda Asset Management Co Ltd. bought a new position in MEDNAX during the 2nd quarter valued at about $217,000. Institutional investors own 98.43% of the company’s stock.
Several equities analysts have issued reports on the stock. SunTrust Banks set a $55.00 target price on shares of MEDNAX and gave the company a “hold” rating in a research note on Thursday, December 21st. Piper Jaffray Companies started coverage on shares of MEDNAX in a research report on Wednesday, December 13th. They set an “overweight” rating and a $58.00 price target for the company. Citigroup reduced their price target on shares of MEDNAX from $52.00 to $47.00 and set a “neutral” rating for the company in a research report on Friday, November 3rd. Robert W. Baird upped their price target on shares of MEDNAX from $47.00 to $48.00 and gave the company a “neutral” rating in a research report on Friday, November 3rd. Finally, Jefferies Group reissued a “hold” rating and issued a $44.00 target price on shares of MEDNAX in a report on Friday, November 3rd. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. MEDNAX currently has a consensus rating of “Hold” and a consensus price target of $53.82.
Shares of MEDNAX Inc (NYSE:MD) traded up $0.05 on Friday, reaching $54.22. 446,418 shares of the company’s stock were exchanged, compared to its average volume of 845,477. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.37 and a current ratio of 1.37. The stock has a market cap of $5,073.30, a price-to-earnings ratio of 19.16, a P/E/G ratio of 1.63 and a beta of 0.39. MEDNAX Inc has a twelve month low of $40.56 and a twelve month high of $72.13.
MEDNAX (NYSE:MD) last posted its earnings results on Wednesday, November 1st. The company reported $0.87 EPS for the quarter, meeting analysts’ consensus estimates of $0.87. The firm had revenue of $868.95 million during the quarter, compared to the consensus estimate of $864.78 million. MEDNAX had a return on equity of 10.80% and a net margin of 7.76%. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.09 EPS. equities research analysts expect that MEDNAX Inc will post 3.1 EPS for the current year.
In other news, insider John C. Pepia sold 3,000 shares of MEDNAX stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $51.58, for a total transaction of $154,740.00. Following the completion of the sale, the insider now directly owns 35,569 shares in the company, valued at $1,834,649.02. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Cesar L. Alvarez sold 10,668 shares of MEDNAX stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $42.59, for a total value of $454,350.12. Following the sale, the director now owns 44,215 shares of the company’s stock, valued at $1,883,116.85. The disclosure for this sale can be found here. 2.40% of the stock is owned by company insiders.
WARNING: This story was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.thelincolnianonline.com/2018/01/13/mednax-inc-md-position-raised-by-public-employees-retirement-system-of-ohio-updated-updated.html.
MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.